AbbVie (Brazil) Today
| ABBV34 Stock | BRL 53.50 0.01 0.02% |
Performance6 of 100
| Odds Of DistressLess than 9
|
AbbVie is trading at 53.50 as of the 18th of April 2024, a -0.02 percent decrease since the beginning of the trading day. The stock's open price was 53.51. AbbVie has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for AbbVie Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. The company has 28.3 B outstanding shares. More on AbbVie Inc
Moving together with AbbVie Stock
| 0.79 | TMCO34 | Toyota Motor | PairCorr |
Moving against AbbVie Stock
| 0.71 | SNEC34 | Sony Group | PairCorr |
| 0.69 | GILD34 | Gilead Sciences | PairCorr |
| 0.64 | BIIB34 | Biogen Inc | PairCorr |
| 0.61 | AAPL34 | Apple Inc | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AbbVie Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AbbVie's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AbbVie or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman of the Board, CEO | Richard Gonzalez |
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
AbbVie Inc (ABBV34) is traded on Sao Paulo Exchange in Brazil and employs 26 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.42 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AbbVie's market, we take the total number of its shares issued and multiply it by AbbVie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AbbVie Inc operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 28.3 B outstanding shares.
AbbVie Inc has accumulated about 5.23 B in cash with 13.8 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.54.
Check AbbVie Probability Of Bankruptcy
AbbVie Stock Price Odds Analysis
What are AbbVie's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of AbbVie jumping above the current price in 90 days from now is about 51.82%. The AbbVie Inc probability density function shows the probability of AbbVie stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon AbbVie has a beta of 0.243. This suggests as returns on the market go up, AbbVie average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AbbVie Inc will be expected to be much smaller as well. Additionally, abbVie Inc has an alpha of 0.1266, implying that it can generate a 0.13 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of AbbVie to move above the current price in 90 days from now is about 51.82 (This AbbVie Inc probability density function shows the probability of AbbVie Stock to fall within a particular range of prices over 90 days) .
AbbVie Inc Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. AbbVie market risk premium is the additional return an investor will receive from holding AbbVie long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AbbVie. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although AbbVie's alpha and beta are two of the key measurements used to evaluate AbbVie's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.03 | |||
| Semi Deviation | 1.51 | |||
| Standard Deviation | 1.38 | |||
| Variance | 1.91 |
AbbVie Stock Against Markets
Picking the right benchmark for AbbVie stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AbbVie stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AbbVie is critical whether you are bullish or bearish towards AbbVie Inc at a given time. Please also check how AbbVie's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in AbbVie without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
AbbVie Corporate Directors
AbbVie corporate directors refer to members of an AbbVie board of directors. The board of directors generally takes responsibility for the AbbVie's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AbbVie's board members must vote for the resolution. The AbbVie board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Brett Hart | Independent Director | Profile | |
| Roxanne Austin | Independent Director | Profile | |
| Edward Rapp | Independent Director | Profile | |
| Frederick Waddell | Independent Director | Profile |
How to buy AbbVie Stock?
Before investing in AbbVie, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in AbbVie. To buy AbbVie stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of AbbVie. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase AbbVie stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located AbbVie Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased AbbVie Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as AbbVie Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy AbbVie Stock please use our How to Invest in AbbVie guide.
Already Invested in AbbVie Inc?
The danger of trading AbbVie Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AbbVie is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AbbVie. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AbbVie Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |